What is Numerion Labs?
Numerion Labs is an AI-native biotechnology firm dedicated to revolutionizing small-molecule medicine discovery. Leveraging a proprietary platform that combines advanced machine learning, computational chemistry, and structural biology, the company explores vast chemical spaces to identify novel therapeutic candidates. Its primary focus lies in addressing immune and inflammatory diseases, aiming to accelerate the development of innovative treatments and enhance the efficiency of the drug discovery pipeline.
How much funding has Numerion Labs raised?
Numerion Labs has raised a total of $19.8M across 1 funding round:
Private Equity
$19.8M
Private Equity (2026): $19.8M, investors not publicly disclosed
What's next for Numerion Labs?
The substantial enterprise-level funding received by Numerion Labs signals a critical inflection point, likely enabling the company to scale its operations, expand its research and development initiatives, and potentially advance its lead drug candidates through clinical trials. This strategic investment is poised to accelerate the company's mission to transform drug discovery and bring novel therapies to patients suffering from complex diseases.
See full Numerion Labs company page
